These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36690262)

  • 21. WTAP promotes macrophage recruitment and increases VEGF secretion via N6-methyladenosine modification in corneal neovascularization.
    Bai Y; Jiao X; Hu J; Xue W; Zhou Z; Wang W
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166708. PubMed ID: 37019244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression.
    Lin Z; Jiang T; Zheng W; Zhang J; Li A; Lu C; Liu W
    Cell Commun Signal; 2023 Aug; 21(1):199. PubMed ID: 37563688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
    Ling Z; Chen L; Zhao J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
    Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
    FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FLOT1, stabilized by WTAP/IGF2BP2 mediated N6-methyladenosine modification, predicts poor prognosis and promotes growth and invasion in gliomas.
    Song T; Hu Z; Zeng C; Luo H; Liu J
    Heliyon; 2023 Jun; 9(6):e16280. PubMed ID: 37260902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WTAP-mediated m6A modification of KLF6 aggravates hypoxia/reoxygenation-induced human cardiomyocyte injury.
    Fang M; Li T; Wu Z
    Shock; 2024 Apr; ():. PubMed ID: 38662610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA CCAT1 knockdown suppresses tongue squamous cell carcinoma progression by inhibiting the ubiquitination of PHLPP2.
    Liu F; Yang H; Liu X; Ning Y; Wu Y; Yan X; Zheng H; Liu C
    Mol Cell Biochem; 2024 May; ():. PubMed ID: 38763996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
    J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.
    An X; Wu W; Yang L; Dong J; Liu B; Guo J; Chen J; Guo B; Cao W; Jiang Q
    Transl Res; 2023 Sep; 259():62-71. PubMed ID: 37121538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-methyladenosine (m6A) RNA methylation mediated by methyltransferase complex subunit WTAP regulates amelogenesis.
    Xie F; Zhu X; Liu X; Chen H; Wang J
    J Biol Chem; 2022 Dec; 298(12):102715. PubMed ID: 36403857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIF-1
    Lyu Y; Zhang Y; Wang Y; Luo Y; Ding H; Li P; Ni G
    J Immunol Res; 2022; 2022():6130806. PubMed ID: 35733918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The m
    Guo S; Zhao C; Fang L; Xu W; Dalia S; Glass J; Shikama N; Zhang Z
    Ann Transl Med; 2022 Jul; 10(14):779. PubMed ID: 35965785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.
    Zhang Y; Tian X; Bai Y; Liu X; Zhu J; Zhang L; Wang J
    Mamm Genome; 2022 Dec; 33(4):654-671. PubMed ID: 36173464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EXOSC2 Mediates the Pro-tumor Role of WTAP in Breast Cancer Cells via Activating the Wnt/β-Catenin Signal.
    Lv CG; Cheng Y; Zhang L; Wu GG; Liang CY; Tao Z; Chen B
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37856011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern.
    You A; Tian W; Yuan H; Gu L; Zhou J; Deng D
    Oncogene; 2022 Aug; 41(32):3925-3938. PubMed ID: 35798874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification.
    Yuan X; Bao Q; Lu B; Xiang C; Hou X; Wei W
    Open Med (Wars); 2023; 18(1):20230818. PubMed ID: 37854284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.
    Chen S; Xia H; Sheng L
    Dig Liver Dis; 2023 Jul; 55(7):967-981. PubMed ID: 36586770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
    Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
    J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.